Sequestration and Hemophilia Research This year’s mandatory federal budget cuts, known as “the sequester,” have been raising concerns about the future of biomedical research... Read More Researcher Profiles, Hemophilia A&B Banding Together for Hemophilia Research Research into treatments and cures for hemophilia takes place in laboratories all over the country. So it’s no wonder that... Read More Researcher Profiles, Hemophilia A&B Research Progress Helps Entire Community Cryoprecipitate. Long-acting factor concentrates. Gene therapy trials. These are just a few of the incredible clinical advances from the past... Read More Research & Treatment, Hemophilia A&B NHF-Shire Clinical Fellow Profile: Michael Callaghan, MD HemAware is conducting a series of interviews with recipients of the NHF-Shire Clinical Fellowship. It is funded through the generous... Read More Researcher Profiles NHF-Shire Clinical Fellow Profile: Neil Goldenberg, MD This interview was conducted with Neil Goldenberg, MD, PhD, director of research at Johns Hopkins-All Children’s Hospital in St. Petersburg... Read More Researcher Profiles Progress Made for My Life, Our Future Genotyping Initiative Five pilot sites have been approved and first patients enrolled Read More Novel Technologies NHF-Shire Clinical Fellow Profile: Shannon Meeks, MD This interview was conducted with Shannon Meeks, MD, assistant professor of pediatrics, Aflac Cancer and Blood Disorders Center, Emory University... Read More Researcher Profiles Genotyping for Progress During the past 20 years, advances in hemophilia treatment, including recombinant factor therapy, have allowed people with hemophilia to take... Read More Novel Technologies, Hemophilia A&B Organ Transplants in HIV-Positive People Update, 7/29/2013: The Senate bill now has 14 co-sponsors and passed in the Senate on June 17, 2013. On July... Read More HIV, Surgery & Transplants NHF Launches My Life, Our Future Genotyping Initiative As CEO of the National Hemophilia Foundation (NHF), I can honestly say this news has been decades in the making... Read More Research & Treatment, Hemophilia A&B Probing Gene Therapy Editor’s Note: This article was funded through an educational grant from Novo Nordisk. Read More Research & Treatment, Hemophilia A&B How Modern Medicine Has Tackled HIV Update, August 2013: The FDA approved Tivicay® (dolutegravir), manufactured by ViiV Healthcare, a GlaxoSmithKline company. Tivicay is an integrase strand... Read More HIV, Novel Technologies Load More
